Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Scleroderma of Lung”

127 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 127 results

Large-scale testing (Phase 3)Study completedNCT00080457
What this trial is testing

Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
Encysive Pharmaceuticals 240
Large-scale testing (Phase 3)Study completedNCT01570764
What this trial is testing

Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease

Who this might be right for
Systemic SclerosisSclerodermaInterstitial Lung Disease+1 more
Assistance Publique - Hôpitaux de Paris 40
Large-scale testing (Phase 3)Looking for participantsNCT06549231
What this trial is testing

Evaluation of Efficacy and Safety of Rituximab and Mycophenolate Mofetil Combination in Patients With Interstitial Lung Disease Related to Systemic Sclerosis

Who this might be right for
Interstitial Lung Disease With Systemic Sclerosis
University Hospital, Tours 102
Post-approval studies (Phase 4)Study completedNCT01042158
What this trial is testing

A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis

Who this might be right for
Pulmonary Arterial HypertensionSystemic SclerosisScleroderma Spectrum of Diseases+2 more
Johns Hopkins University 25
Not applicableStudy completedNCT01758250
What this trial is testing

Microvascular and Fibrosis Imaging Study

Who this might be right for
Autoimmune DiseasesSickle Cell DiseaseChronic Graft Versus Host Disease
Duke University 63
Testing effectiveness (Phase 2)Ended earlyNCT00377455
What this trial is testing

Placebo Controlled Trial of Bosentan in Scleroderma Patients

Who this might be right for
Systemic SclerodermaPulmonary Hypertension
Georgetown University 5
Not applicableLooking for participantsNCT06865118
What this trial is testing

Home-Based Clinical Management of Cardiac Complications in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis (SSc)Pulmonary Arterial Hypertension (PAH)Home Monitoring Follow-up
Oslo University Hospital 20
Large-scale testing (Phase 3)Study completedNCT03313180
What this trial is testing

A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 444
Testing effectiveness (Phase 2)Looking for participantsNCT06195072
What this trial is testing

Platform Clinical Study for Conquering Scleroderma

Who this might be right for
Interstitial Lung Disease Due to Systemic DiseaseScleroderma
Scleroderma Research Foundation, Inc. 400
Testing effectiveness (Phase 2)Study completedNCT01988506
What this trial is testing

Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisSystemic Lupus Erythematosus+11 more
Assistance Publique - Hôpitaux de Paris 81
Not applicableEnded earlyNCT02246348
What this trial is testing

Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc)

Who this might be right for
Systemic SclerosisPulmonary Hypertension
Echosense Ltd. 5
Testing effectiveness (Phase 2)Ended earlyNCT04837131
What this trial is testing

Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients

Who this might be right for
Systemic SclerosisSclerodermaDiffuse Systemic Sclerosis+16 more
Michael M. Pham 4
Large-scale testing (Phase 3)Looking for participantsNCT05878717
What this trial is testing

The Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Who this might be right for
Systemic Sclerosis Associated Interstitial Lung DiseaseScleroderma, Systemic
GlaxoSmithKline 300
Testing effectiveness (Phase 2)Study completedNCT05559580
What this trial is testing

A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms

Who this might be right for
Scleroderma, Systemic
Boehringer Ingelheim 214
Not applicableStudy completedNCT03601520
What this trial is testing

Mechanisms of Pulmonary Diffusion Limitation in Systemic Sclerosis

Who this might be right for
Diffusion Limitation of Pulmonary Gas Exchange in Systemic Sclerosis
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 100
Testing effectiveness (Phase 2)Ended earlyNCT05339087
What this trial is testing

Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH

Who this might be right for
Pulmonary Vascular DisorderPrimary Pulmonary HypertensionSystemic Sclerosis+1 more
Heidelberg University 35
Early research (Phase 1)Study completedNCT02426229
What this trial is testing

Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma

Who this might be right for
SclerodermaInterstitial Lung Disease
Medical University of South Carolina 15
Testing effectiveness (Phase 2)Ended earlyNCT05785624
What this trial is testing

A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease

Who this might be right for
Idiopathic Pulmonary FibrosisSystemic Sclerosis With Lung Involvement
Genentech, Inc. 286
Testing effectiveness (Phase 2)Study completedNCT01933334
What this trial is testing

Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)

Who this might be right for
Systemic Sclerosis
Genentech, Inc. 63
Testing effectiveness (Phase 2)Study completedNCT00764309
What this trial is testing

Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis

Who this might be right for
Scleroderma
Bristol-Myers Squibb 47
Next Page